Company Overview and News

18
Wealthy Asians Are Getting Richer Faster Than Anyone Else - Bloomberg

21h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
DBSDY DSLV VIIX DGLD CSSLF VIIZ CS CSGKF D05 UGLD DBSDF ZIV USLV TVIX XIV

29
Vietcombank said to tap Credit Suisse to find insurance partner

2018-06-22 theedgemarkets
SINGAPORE/HANOI (June 22): Bank for Foreign Trade of Vietnam JSC, the nation’s biggest listed lender by market value, appointed Credit Suisse Group AG to advise on finding a new insurance distribution partner, people with knowledge of the matter said.
MFC.PR.B MFC.PR.F DGLD MFC.PR.C BNPQY CS UGLD D05 DBSDF DSLV DBSDY VIIX CSSLF VIIZ BNPQF BNPZY CSGKF MFC 0945 MFC.PR.I MFC.PR.J ZIV USLV MFC MFC.PR.H TVIX 8750 MFC.PR.M MFC.PR.N MFC.PR.K MFC.PR.L XIV

5
Global risks, low inflation await Malaysia's central bank chief

2018-06-22 theedgemarkets
KUALA LUMPUR (June 22): Malaysia’s new central bank governor will inherit economic stability with a dose of political uncertainty and global pressures when she takes office.
DBSDY D05 DBSDF

86
Singapore, Hong Kong push to go cashless, as China pulls ahead in electronic payments

2018-06-21 scmp
Like Hong Kong, Singapore is nudging its population to embrace mobile payments. The city state has pledged to reduce cash withdrawals at ATMs and phase out paper checks by 2025
BABA DBSDY D05 DBSDF 0700

109
Singapore pledges to cut cash, cheques on path to digital economy

2018-06-21 malaymail
SINGAPORE, June 21 — Singapore is accelerating the shift toward digital payments by pledging to eliminate cheque usage by 2025 and slash cash withdrawals from automated telling machines.
STAN C.WSA MLYNF HSB C.WS.B D05 DBSDF STAB C.WS.A STAC SCBFF STAN C.PRP C.PRU HSBC.PRA HSBC HBCYF C.PRS HCS.PRB UOVEF DBSDY MLYBY C C.PRL C.PRJ C.PRK C.PRG HCS O39 U11 C.PRC 0005 1155 C.PRPCL CGBBW 580001 UOVEY 2888 HSEA HSEB

12
Noble Group paves way for debt deal as Goldilocks backs plan

2018-06-20 malaymail
SINGAPORE, June 20 — Embattled commodity trader Noble Group Ltd reached a deal with dissident shareholder Goldilocks Investment Co over its planned US$3.5 billion (RM14 billion) debt restructuring, agreeing to boost the holding in the new company that stock investors stand to get. The shares surged.
DBSDY D05 NOBGF N21 DBSDF NOBGY

28
SE Asian stocks decline; worsening US-China trade spat unnerves investors

2018-06-19 theedgemarkets
(June 19): Southeast Asian stock markets declined on Tuesday, with Thailand and Vietnam closing more than 2% lower, as escalating US-China trade tensions led to a broad sell-off in regional equities.
JGSMY DBSDY PBLOF SVTMF MLYBY JGS MLYNF BDOUY SM 1295 O39 BDOUF 1155 BDO D05 SMIVY DBSDF JGSHF

18
Wealthy Asians are getting richer faster than anyone else

2018-06-19 theedgemarkets
SINGAPORE (June 19): Rich Asians got richer faster than anyone else in the world last year.
DBSDY DSLV VIIX DGLD CSSLF VIIZ CS CSGKF D05 UGLD DBSDF ZIV USLV TVIX XIV

9
Young, Female, and Smarter Than Their Bankers - Bloomberg

2018-06-14 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
HCS.PRB DBSDY HCS HSB 0005 D05 UBS DBSDF HSEA UBS.PRDCL HSEB HSBC.PRA HSBC ULSGF HBCYF

11
South-east Asia stocks fall after Fed hike, Thailand hits six-month low

2018-06-14 malaymail
SINGAPORE, June 14 — South-east Asian stock markets traded lower today, with Thai shares hitting six-month lows, after the US Federal Reserve raised rates, as expected, and took a more hawkish tone regarding the pace of rate hikes for the rest of the year.
SMPH DBSDY D05 DBSDF SPHXY SPHXF SPHZF

28
Most South-east Asia shares fall ahead of Fed decision, Philippines down over 2pc

2018-06-13 malaymail
SINGAPORE, June 13 — Most South-east Asian stock markets declined today, in line with broader Asia ahead of the US Federal Reserve's policy decision which could give cues on future rate hikes.
UOVEF JGSMY DBSDY PBLOF SVTMF JGS BDOUY SM 1295 U11 BDOUF BDO D05 SMIVY DBSDF UOVEY JGSHF

100
Hong Kong banks, meet the 21st century

2018-06-04 bworldonline
IRONICALLY, the city that should have been first to be swept up by China’s fintech revolution is still a picture of old-world conservatism. Not for long, though. Hong Kong, whose last big innovation in retail payments is as old as the former British colony’s 1997 handover to China, is on the cusp of big change.
HCS.PRB STAN DBSDY MTRJY HCS HSB 0005 BABA D05 DBSDF STAB 580001 STAC SCBFF 0700 STAN 2888 HSEA HSEB HSBC.PRA HSBC HBCYF

278
Fintech Battle Pits Biggest Singapore Bank Against China Giants - Bloomberg

2018-05-15 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
FB DBSDY C.WSA C C.PRL C.PRJ C.PRK C.PRG C.PRC C.WS.B D05 C.PRPCL DBSDF CGBBW C.WS.A 0700 AAPL C.PRP C.PRU C.PRS

19
What polls result means for economy and markets

2018-05-10 thestar.com.my
Fuel subsidies: The coalition promised to reintroduce petroleum subsidies, which could be a boon for consumption as the new government eyes a 6 growth goal.
DBSDY MS.PRE NAB NASXF MS.PRF MS.PRG NABZY MS.PRA NAUBF D05 MS.PRI DBSDF MS.PRK MS

9
Emerging market sell-off has Indonesia in crosshairs

2018-05-08 bworldonline
INDONESIA’S market rout shows no signs of abating, with its two-year bonds the latest to be dumped in anticipation that the central bank may need to raise rates to defend its currency.
DBSDY D05 DB DBSDF

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...